小剂量左旋多巴和多巴胺激动剂治疗有效。
Low dose levodopa and dopamine agonists are effective in controlling most symptoms of the disorder.
患者可选用其它治疗药物，包括三种与心脏瓣膜疾病无关的其它多巴胺激动剂。
There are alternative therapies available for Parkinson's disease, including three other dopamine agonists that have not been associated with valvular heart disease.
目前的研究目的是评估使用多巴胺激动剂治疗的泌乳素瘤病人瓣膜性心脏病的患病率。
The aim of the present study was to assess the prevalence of valvular heart disease in patients treated with dopamine agonists for prolactinomas.
目的：使用麦角衍生的多巴胺激动剂，已经证实帕金森病人使用培高利特和卡麦角林可能增加瓣膜心脏病。
Objective: Treatment with ergot-derived dopamine agonists, pergolide, and cabergoline has been associated with an increased frequency of valvular heart disease in Parkinson's disease.
结论视幻觉是PD患者常见的一种非运动性症状，认知功能、病情严重程度、多巴胺激动剂的使用可能与视幻觉的发生有关。
Conclusion visual hallucination is a common non-motor symptom among patients with PD, and cognitive function, disease severity and usage of dopamine agonists may be related to visual hallucination.
目的研究多巴胺受体激动剂对乙醇引起大鼠纹状体抗坏血酸(AA)释放的影响。
AIM to study the effects of dopamine receptor agonists on ethanol induced striatal ascorbic acid (AA) release in rats.
目的：对比分析多巴胺1受体激动剂非诺多泮对兔肺动脉和肠系膜动脉的影响。
Objective: To evaluate and compare the effects of DA 1 receptor agonist, fenoldopam, rabbit pulmonary and mesenteric arteries.
前言： 目的：合成多巴胺D，受体部分激动剂BP897。
Objective:To synthesize BP897, a dopamine D3 receptor partial agonist.
前言： 目的：合成多巴胺D，受体部分激动剂BP897。
Objective:To synthesize BP897, a dopamine D3 receptor partial agonist.
应用推荐